Skip to Content

Podcast Alert: Dr. Eli Meltzer Discusses New Data on Fluticasone Furoate Nasal Spray

SAN DIEGO, Calif., Feb. 27 /PRNewswire/ -- You are invited to listen to world-renowned allergist Eli Meltzer, M.D. discuss new data on fluticasone furoate nasal spray that was recently presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).

    What:     Dr. Eli Meltzer Discusses New Data on Fluticasone Furoate Nasal


    When:     Podcast available for download on February 27, 2007, 2007


    How:      Log into the URL above and follow the subscription instructions

              on the website

    Contact:  Janene Ferrara of Marina Maher Communications, 212-485-6843

              Dr. Meltzer is available for interviews

Dr. Meltzer is co-director of Allergy & Asthma Medical Group and Research Center, as well as Clinical Professor of Pediatrics at the University of California, both in San Diego. He has participated in nearly 600 research studies focused on various aspects of respiratory disease and authored more than 400 scientific publications.

Fluticasone furoate nasal spray is an enhanced affinity intranasal corticosteroid (INS) currently in development by GlaxoSmithKline (GSK) for use in the treatment of allergic rhinitis. The new agent is currently under review by the U.S. Food and Drug Administration to treat the symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).

Minimum Requirements: a computer, a broadband Internet connection, a portable MP3 player or MP3-player application on your computer, podcasting software and QuickTime 7. If you experience problems downloading the podcast, send an email to .

CONTACT: Janene Ferrara of Marina Maher Communications, +1-212-485-6843

Web site:

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Posted: February 2007